SEER - Seer Inc logo

SEER

Seer Inc

Seer, Inc. develops and commercializes products for proteomic analysis, offering solutions like the Proteograph Product Suite, which includes engineered nanoparticles, consumables, and data analysis software for research use in labs and biopharmaceutical companies.

⚕️ Healthcare NASDAQ Listed 2020 $ USD
$1,000 invested 5 years ago $72today

Score Overview

1 Year
Score
Net Growth4.23%
Net TrendGrew
Net Income Consistency
Rev Growth-8.93%
Rev TrendShrank
Revenue Consistency
5 Years
Score5.3
Net Growth0.96%
Net Trend60%
Net Income Consistency
Rev Growth129.59%
Rev Trend60%
Revenue Consistency
All Time
Score
Net Growth-115.07%
Net Trend50%
Net Income Consistency
Rev Growth22x
Rev Trend67%
Revenue Consistency

See the full market ranking →

Seer Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 656K to $ 16M and net income went from -$ 32M to -$ 73M. Revenue increased in 3 of those 5 years; net income in 3.

Seer Inc currently holds a 5-year HDB Score of 5.3 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 2.14
1 Year2025-08-12
$ 2.20-2.73%
5 Years2021-08-12
$ 29.85-92.83%
All Time2020-12-04
$ 56.46-96.21%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 14M-$ 70M$ 166M
2025$ 16M-$ 73M$ 185M
2024$ 13M-$ 86M$ 236M
2023$ 15M-$ 86M$ 316M
2022$ 14M-$ 92M$ 421M
2021$ 6M-$ 71M$ 400M
IPO2020$ 656K-$ 32M$ 431M

Explore beyond SEER

You're looking at Seer Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies